Gut microbiota, obesity and diabetes
- E. Patterson; P. M. Ryan; J. F. Cryan; T. G. Dinan; R. P. Ross; G. F. Fitzgerald; C. Stanton Gut microbiota, obesity and diabetes Postgrad Med J
Publication Category: Microbiome
The Gut Microbiota Profile in Children with Prader-Willi Syndrome
-
Y. Peng; Q. Tan; S. Afhami; E. C. Deehan; S. Liang; M. Gantz; L. Triador; K. L. Madsen; J. Walter; H. M. Tun; A. M. Haqq
The Gut Microbiota Profile in Children with Prader-Willi Syndrome Genes (Basel)
Gut microbiota modulation with long-chain corn bran arabinoxylan in adults with overweight and obesity is linked to an individualized temporal increase in fecal propionate
-
N. K. Nguyen; E. C. Deehan; Z. Zhang; M. Jin; N. Baskota; M. E. Perez-Muñoz; J. Cole; Y. E. Tuncil; B. Seethaler; T. Wang; M. Laville; N. M. Delzenne; S. C. Bischoff; B. R. Hamaker; I. Martínez; D. Knights; J. A. Bakal; C. M. Prado; J. Walter
Gut microbiota modulation with long-chain corn bran arabinoxylan in adults with overweight and obesity is linked to an individualized temporal increase in fecal propionate Microbiome
Prebiotic dietary fibre intervention improves fecal markers related to inflammation in obese patients: results from the Food4Gut randomized placebo-controlled trial
-
A. M. Neyrinck; J. Rodriguez; Z. Zhang; B. Seethaler; C. R. Sánchez; M. Roumain; S. Hiel; L. B. Bindels; P. D. Cani; N. Paquot; M. Cnop; J. A. Nazare; M. Laville; G. G. Muccioli; S. C. Bischoff; J. Walter; J. P. Thissen; N. M. Delzenne
Prebiotic dietary fibre intervention improves fecal markers related to inflammation in obese patients: results from the Food4Gut randomized placebo-controlled trial Eur J Nutr
Antimicrobials: Strategies for targeting obesity and metabolic health?
-
E. F. Murphy; S. F. Clarke; T. M. Marques; C. Hill; C. Stanton; R. P. Ross; R. M. O'Doherty; F. Shanahan; P. D. Cotter
Antimicrobials: Strategies for targeting obesity and metabolic health? Gut Microbes
Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity
-
E. F. Murphy; P. D. Cotter; A. Hogan; O. O'Sullivan; A. Joyce; F. Fouhy; S. F. Clarke; T. M. Marques; P. W. O'Toole; C. Stanton; E. M. M. Quigley; C. Daly; P. R. Ross; R. M. O'Doherty; F. Shanahan
Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity Gut
The microbiota and bariatric surgery: it’s a bug’s life
-
E. F. Murphy; E. M. Quigley
The microbiota and bariatric surgery: it’s a bug’s life Gastroenterology
Gut microbiota and obesity: role in aetiology and potential therapeutic target
-
C. P. Moran; F. Shanahan
Gut microbiota and obesity: role in aetiology and potential therapeutic target Best Pract Res Clin Gastroenterol
Interleukin-36 cytokines alter the intestinal microbiome and can protect against obesity and metabolic dysfunction
-
E. Giannoudaki; Y. E. Hernandez-Santana; K. Mulfaul; S. L. Doyle; E. Hams; P. G. Fallon; A. Mat; D. O'Shea; M. Kopf; A. E. Hogan; P. T. Walsh
Interleukin-36 cytokines alter the intestinal microbiome and can protect against obesity and metabolic dysfunction Nat Commun